RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spot hidden breast cancer before scans do
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer (triple-negative) who still have cancer cells left after standard treatment and surgery. Researchers will use a special blood test (ctDNA) to look for tiny traces of cancer DNA that scans might miss. If the test find…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a Copper-Lowering drug help stop Triple-Negative breast cancer recurrence?
Disease control Recruiting nowThis study tests whether adding a drug called tetrathiomolybdate (TM) to standard chemotherapy (capecitabine) can reduce the risk of cancer spreading in people with high-risk triple-negative breast cancer. The trial has two parts: first, a small safety phase, then a larger random…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC